Integrated Ligand and Structure based approaches towards developing novel Janus Kinase 2 inhibitors for the treatment of myeloproliferative neoplasms
Ambili P Unni, Girinath G. Pillai, Lulu.S Sajitha
The paper identifies novel JAK2 inhibitors using ligand and structure-based approaches to address adverse drug reactions in MPNs treatment.
bioRxiv · Nov 26, 2020 · PreprintBioinformatics